Rearrangements of <i>ATP5L‐KMT2A</i> in acute lymphoblastic leukaemia
Anna Ferrari(University of Bologna), Giovanni Martinelli(University of Bologna), Andrea Ghelli Luserna di Rorà(Fondazione Pisa), Jesús María Hernández‐Rivas(Universidad de Salamanca), Cristina Papayannidis(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Annalisa Imovilli(Azienda Sanitaria Unità Locale di Reggio Emilia), Chiara Domizio(University of Ferrara), Giorgia Simonetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Ilaria Iacobucci(St. Jude Children's Research Hospital), Elisabetta Abruzzese(St. Eugenio Hospital), Fabio Giglio(IRCCS Ospedale San Raffaele), Daniele Calistri(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Michela Rondoni(Azienda Unità Sanitaria Locale Della Romagna)
Cited by 5
Related Papers
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Non-coding recurrent mutations in chronic lymphocytic leukaemia
|Nature|2015|851